| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $138.7M | -0.9% |
| Cost of Revenue | $31.3M | +75.5% |
| R&D Expense | $12.3M | -25.1% |
| SG&A Expense | $25.1M | +14.0% |
| Operating Income | $70.0M | -16.3% |
| Pre-tax Income | $76.1M | -13.3% |
| Income Tax | $16.9M | -14.5% |
| Net Income | $59.2M | -13.0% |
| EPS (Basic) | $0.83 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $155.4M | +3.5% |
| Accounts Receivable | $21.2M | +0.2% |
| Inventory | $49.6M | -22.8% |
| Current Assets | $231.0M | -3.3% |
| Total Assets | $244.3M | -3.9% |
| Current Liabilities | $25.3M | -53.2% |
| Total Liabilities | $28.5M | -50.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $48.8M | -48.6% |
| Capital Expenditures | $42K | +95.7% |
| Investing Cash Flow | -$42K | -95.7% |
| Financing Cash Flow | -$43.5M | -0.1% |
| Free Cash Flow | $48.7M | -48.6% |
| -12.6% |
| EPS (Diluted) | $0.82 | -13.7% |
| Stockholders' Equity |
| $215.8M |
| +9.6% |